Nurix Therapeutics has reported positive clinical data from its ongoing Phase Ia/Ib trial of NX-5948 for Waldenstrom's ...

RZ-402 has the potential to treat or prevent DME, and influence both clinical practice and patient burden experienced by DME ...

Vabysmo is the first drug of its kind to receive approval for diabetic macular oedema treatment. Credit: Prostock-studio / ...

The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

Amylyx Pharmaceuticals has announced positive results from the trial, indicating sustained improvements with AMX0035 in ...

Response Pharmaceuticals has initiated subject enrolment for a Phase II trial of its drug candidate RDX-002, designed to ...

The trial demonstrated a median reduction in EEG seizure burden Credit: Ground Picture/Shutterstock. Marinus Pharmaceuticals has reported results from the pivotal Phase III RAISE trial for intravenous ...

Clesrovimab is a single-dose extended half-life monoclonal antibody developed as a passive immunisation for the prevention of RSV. Credit: Sergiy Palamarchuk ...

The upcoming two-day event delves into the clinical trial landscape and the strategies employed to increase the region’s ...

NovoCure’s Optune Lua, a wearable indicated for patients with metastatic non-small cell lung cancer has received approval ...

Integrated clinical trial network Eximia Research has expanded into Iowa, US, with the acquisition of Integrated Clinical ...